NBY: NovaBay Pharmaceuticals, Inc. Stock

by  •  • Comments Off on NBY: NovaBay Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3.23
Enterprise Value ($M) 3.19
Book Value ($M) 3.31
Book Value / Share 0.09
Price / Book 0.97
NCAV ($M) 1.43
NCAV / Share 0.04
Price / NCAV 2.25

Profitability (mra)
Return on Invested Capital (ROIC) -1.59
Return on Assets (ROA) -0.65
Return on Equity (ROE) -1.08

Liquidity (mrq)
Quick Ratio 1.00
Current Ratio 1.67

Balance Sheet (mrq) ($M)
Current Assets 7.15
Assets 9.03
Liabilities 5.72
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 14.73
Operating Income -5.00
Net Income -9.64
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -4.13
Cash from Investing -0.02
Cash from Financing 1.91

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Armistice Capital, Llc 4.99 98.59
02-13 13G/A Altium Capital Management LP 4.99
02-06 13G/A Hudson Bay Capital Management LP 9.99 218.13

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-29 10-K/A  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1
2024-03-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-02 178,481 510,767 34.94
2024-05-01 418,493 1,295,331 32.31
2024-04-30 236,500 1,161,399 20.36
2024-04-29 216,079 771,012 28.03

(click for more detail)

Similar Companies
LCTX – Lineage Cell Therapeutics, Inc. MAIA – MAIA Biotechnology, Inc.
MTNB – Matinas BioPharma Holdings, Inc. NNVC – NanoViricides, Inc.
OGEN – Oragenics, Inc.


Financial data and stock pages provided by
Fintel.io